Table 3 Missense and silent mutations in samples categorized by the presence of driver mutations in EGFR and KRAS genes.

From: Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden

Sample type

Number of samples

Number of missense mutations

Number of silent mutations

Density missense (per sample, per site)

Density silent (per sample, per site)

dN/dS

Driver mutations in EGFR

69

14,700

6035

2.88E-06

3.86E-06

0.75 ± 0.03

No driver mutations in EGFR

2362

855,254

291,208

4.89E-06

5.44E-06

0.89 ± 0.01

Driver mutations in KRAS

160

80,537

24,213

6.80E-06

6.68E-06

1.02 ± 0.02

No driver mutations in KRAS

2271

789,200

272,442

4.69E-06

5.30E-06

0.89 ± 0.01